A great collaboration by Toronto's KalGene and CIMTEC with NRC and McGill. A Canadian powerhouse!
KalGene gears up to manufacture and test promising Alzheimer's treatment with NRC, McGill and CIMTEC - Canada News Centre
KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel Alzheimer's treatment in Canada that the parties have been co-developing since 2015.
Join in on the conversation with Ella Korets-Smith when you subscribe to Toronto Health.